Merger mayhem of Q422 continues and the Spine enabling tech space heats up with new navigation products and some robotics players seeing record-breaking sales and unit placements.

The Q422 WW Spine Enabling Tech Market was up +13.6% YoY, according to SmartTRAK Financial Dashboard. Medtronic (MDT) remained the market leader, followed by Globus Medical (GMED) and other enabling tech competitors like Brainlab and Stryker (SYK). For detailed Q422 revenues and shares by company in the US, EU and ROW, see SmartTRAK Spine Enabling Tech Financial Dashboard*.

• Complete Q422 Spine Enabling Tech Performance Recap
• Mighty Mergers in Q422 and Q123
  • SeaSpine and Orthofix Take the Plunge
  • Globus and NuVasive Join Forces in Q123
    
• Other Q422 Collaborations
  • ZimVie and Brainlab
  • Spineart and eCential Robotics
  • Captiva Spine and REMEX Medical
• Q422 Augmented Reality and Navigation Regulatory Highlights

Read the entire Q422 Spine Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

More than just robots. Targeting enabling technologies to the ASC setting, development of novel assistive technologies, next-generation software updates, new applications and data insights abound at AAOS 2023.

In the US Markets for Spine and Orthopedic Enabling Technologies, it’s clear that companies are rapidly innovating and designing next-generation technologies that continue to advance the market well beyond the robotic surgical arms and platforms developed in the last decade. At this year’s American Academy of Orthopaedic Surgeons’ (AAOS) Annual Meeting, enabling technology was a big focus both on the podium and the exhibit floor. The Canaccord Genuity (CG) Musculoskeletal Conference also included a number of presentations from companies with innovative enabling technologies, including Enovis, OnPoint Surgical, THINK Surgical, OrthAlign, Augmedics, Canary Medical and newcomer Caira. Additionally, several companies on the AAOS exhibit floor were showcasing new developments across surgical planning, navigation, augmented reality, robotics and smart implants. In this Perspective article, SmartTRAK focuses in on several of the aforementioned companies, exciting technologies and important topics, including:

• These Are Not Your Father’s Robots: They're Here to Stay
• ASC Shift Driving Smaller, More Cost-Effective Solutions
• Dream Becoming Reality: Augmented Reality Competition Heats Up
• More Than Just Data: Smart Implants Show Promise in Improving Post-op Recovery
• Enabling Technology Space Continues to Grow
• Physician Adoption

With a lot of new developments expected later this year and over the next 24-48 months, the enabling technology space continues to grow and physician adoption is ...

To download and read the complete and unedited "Beyond Robotics: Enabling Tech Innovations at AAOS 2023" article by Elise Wolf, GM & VP, SmartTRAK Orthopedics, Digital & Quality, just click the button below.

Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under development by a host of companies in the market for spine enabling tech.

Q322 was nothing short of a tidal wave of competitive entrants to the US Spine Robotic Surgery space. Medtronic* (MDT) and  Globus* remain top players as OUS companies like France’s  eCential Robotics* and Taiwan’s  Point Robotics MedTech* set their sights on the US market. The Q322 WW CAS Spine Market was up, according to  SmartTRAK Financial Dashboard. MDT remained the market leader with 49.0% share, followed by Globus and other enabling tech competitors like Brainlab* and Stryker* (SYK).

Among the many topics covered in detail in our comprehensive Q322 CAS Spine Market Recap* are:

For the first time in recent years, robotics was not a main headline in the academic program at NASS 2022, but SmartTRAK notes that the exhibit floor was buzzing with exciting new developments in enabling technology.

Although there were limited program sessions focused solely on enabling technology at NASS 2022, the floor was abuzz with digital solutions, including recently launched and upcoming products. Based on conversations with NASS exhibitors, SmartTRAK identified key trends in the market for spine enabling technology including new spine robotic systems, augmented reality (AR) platforms and compact navigation solutions, as well as advances in surgical planning and unveiling of digital ecosystems. These innovations will help drive double-digit growth in the US market for Spine Enabling Technologies.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

• Beyond Robotics: Leveraging Data and Ecosystems
• Battle Bots: New Spine Robots on Display
• Augmented Reality Positioned to Target ASCs
• Small-Footprint Platforms and Disposable Spinal Navigation
• Problem-Solving Differentiated Technology

Spine enabling tech companies continue to report positive momentum moving into H222 despite limited hospital budgets, chip shortages and continued staffing issues. The North American Spine Society (NASS) 2022 annual meeting next week is sure to provide a preview of what is coming next for both spine robotics from players like Medtronic and Globus, as well as surgical guidance solution providers such as NuVasive and SeaSpine. We are also looking forward to new enabling tech solutions to be launched at the meeting.

Our spine experts will be roaming the floor, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest in the CAS Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.

To make sure you’re up to speed before the meeting, here is a sample of recent CAS Spine news collected and curated by the expert analysts at SmartTRAK. If you would like to book a meeting with us at NASS, please click the button below. New Products:

• Stryker*
  

  SYK announced the launch of its Q Guidance System for spine applications, which includes surgical planning and intra-op guidance for spine procedures in patients age 13 and older.

A market fraught with challenging hospital budgets, chip shortages and continued staffing issues results in apparent swings in robotic performance. On the other hand, enabling tech platforms companies continue to report positive momentum moving into H222.

The Q222 WW CAS Spine Market was down YoY according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader, followed by Globus* (GMED) and other enabling tech competitors including Stryker* (SYK) and Brainlab*. For detailed Q222 revenues and shares by company in the US, EU and ROW, see SmartTRAK CAS Spine Financial Dashboard*.

Among the many topics covered in detail in our comprehensive Q222 Computer Assisted Surgery Spine Market Recap* are:

• Complete Q222 CAS Spine Market Overview and Highlights
• SmartTRAK's Expert Analysis and Insights
• All Company News including Revenues, Data, Charts and Shares
• Variable Robotics Performance in a Difficult Climate

The first half of 2022 has delivered both positive and negative developments for the Computer-Assisted Surgery industry. Supply chain issues and surges of COVID-19 infections have continued to have significant impacts on revenues. At the same time, enabling tech product launches proceed at a rapid pace, with some robotic procedures accelerating. The following is a sample of recent CAS news and developments from around the world, compiled by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more.

New Products:

• Globus*
  

  GMED announced completion of the first clinical cases using Excelsius3D w/ the ExcelsiusGPS platform. The surgeries were completed at MedStar Union Memorial Hospital in MD, Northwest Specialty Hospital in ID & NYU Langone Health in NY.

• SeaSpine*

  SPNE touted the Q122 limited commercial launch of FLASH Navigation Lumbar Facet Fusion, which facilitates delivery of OsteoStrand Plus DBM Fiber pellets in spine MIS procedures. It is SPNE’s first procedural solution w/ integrated 7D technology. SPNE Q122 Earnings Press Release

Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accelerate, and companies continue roll out new spine enabling technology and strategize how to maximize the remainder of 2022.

The Q122 WW CAS Spine Market was up year-over-year according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader with 59.5% share, followed by Globus* (GMED) and other enabling tech competitors, including Stryker* (SYK) and Brainlab*. 

Among the many topics covered in detail in our comprehensive Q122 CAS Spine Market Recap* are:

Erez Lampert, CEO and Founder of Israeli start-up Pathkeeper Surgical, discusses the Company’s real-time spinal navigation system that’s generating high interest from ASCs in an interview with SmartTRAK 

In an interview with SmartTRAK, Pathkeeper Surgical CEO and Founder Erez Lampert discusses Pathkeeper’s mobile, light-weight spinal navigation system. 

To find out more, including the timeline for FDA approval and demand from surgeons, hospitals and ASCs, click on the following video to listen to the full interview (22:29 min). A link to download the complete transcript of the interview is also provided below.